Podcast

LeVar Burton Helping the MPN Community Through Advocacy and Storytelling

Author(s):

Jamie Cesanek,Darlene Dobkowski, MA

On this episode of the “Cancer Horizons” podcast, LeVar Burton sits down with CURE® to talk about the importance of MPN awareness and the power of storytelling in advocacy.

LeVar Burton knows the importance of storytelling quite well, as an actor, director and advocate for children’s literacy. In an interview with CURE®, he explained how he’s using storytelling to connect with the MPN community and inspire others to share their stories.

Related Videos
A man with a dark gray button-up shirt with glasses and cropped brown hair.
MPN Hero, Ed Bartholemy in an interview with CURE
Julie Huynh-Lu in an interview with CURE
Related Content
FDA approves Ryoncil for children with GVHD.
December 18th 2024

Ryoncil Receives FDA Approval for Children With GVHD

Darlene Dobkowski, MA
This marks the first mesenchymal stromal cell therapy approved by the FDA for children with acute graft versus host disease.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Image of blood test.
December 8th 2024

Navtemadlin Shows Biomarker Response in Patients with R/R Myelofibrosis

Morgan Bayer
Patients with relapsed or refractory (R/R) myelofibrosis experienced reduced biomarkers of disease severity following treatment with navtemadlin.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Illustration of blood cells.
November 4th 2024

Jakafi, Pegasys Combination Beneficial in Newly Diagnosed Polycythemia Vera

Alex Biese
Among patients with polycythemia vera, the treatment pairing of Jakafi and Pegasys shows benefits with acceptable toxicity, research showed.
Illustration of bone marrow.
October 31st 2024

Inrebic May Reduce Spleen Volume in Myelofibrosis

Alex Biese
Second-line treatment with Inrebic has been shown to be beneficial for patients with myelofibrosis previously treated with Jakafi.